Drug Search Results
More Filters [+]

Rimonabant

Alternative Names: rimonabant, sr141716
Latest Update: 2024-09-23
Latest Update Note: News Article

Product Description

Mechanisms of Action: CB1 Antagonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Colombia | European Medicines Agency | Germany | Hungary | India | Ireland | Italy | Peru | Portugal | Slovenia | Sweden | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Rimonabant

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Obesity, Abdominal|Diabetes, Gestational|Obesity|Insulin Resistance|Other|Overweight|Healthy Volunteers|Dyslipidemia|Inflammation

Phase 3: Type 2 Diabetes|Other|Obesity|Fatty Liver, Alcoholic|Non-alcoholic Fatty Liver Disease|Obesity, Abdominal|Albuminuria|Dyslipidemia|Prediabetic State|Glucose Intolerance|Weight Loss|Arteriosclerosis|Carotid Stenosis|Overweight|Smoking Cessation|Tobacco Use Disorder|Stroke|Myocardial Infarction|Atherosclerosis|Myocardial Ischemia|Coronary Artery Disease|Schizophrenia|Metabolic Syndrome X|Spinal Cord Injuries|Weight Gain|Non-alcoholic Steatohepatitis|Prader-Willi Syndrome|Hepatitis, Alcoholic

Phase 2: Obesity|Polycystic Ovary Syndrome|Hypertension|Marijuana Abuse|Tobacco Use Disorder|Affective Disorders, Psychotic|Alcoholic Intoxication|Schizophrenia|Psychotic Disorders|Spinal Cord Injuries

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2022-001522-30

P3

Active, not recruiting

Spinal Cord Injuries

2024-09-29

RIMOFATSCI-2

P2

Unknown status

Spinal Cord Injuries

2023-11-01

RIMOFATSCI-1

P2

Completed

Spinal Cord Injuries

2022-06-07

Effec Acomplia gastric sensitivity

P4

Completed

Healthy Volunteers

2021-03-03

Recent News Events